Curious About InMode?
When researching skin lifting or elasticity treatments, you will often come across the name "InMode." It is widely known as an RF (radio-frequency) device — yet when you ask "what exactly does it do, what concerns does it address, and what kind of results does it produce?", the information available tends to be vague.
This article draws on the approach Dr. Kim Gun-woo, Medical Director of Cellinique on Dosan-daero in Gangnam, takes during consultations and during InMode treatments, and summarizes what is currently confirmed about RF-based procedures. If you are also interested in comparing other lifting and elasticity treatments, see the Skin Booster Comparison Guide or the Cellinique Lifting Treatment Information page.
3-Line Summary
1. InMode is a medical-device platform that delivers RF (Radio Frequency) energy to the dermal layer of the skin to induce collagen remodeling. It operates a range of applicators (Forma, FX, Morpheus8, and others) matched to the handpiece and target indication.
2. Morpheus8 (fractional RF microneedling) holds US FDA 510(k) clearance and is used in the direction of skin regeneration and elasticity improvement. However, domestic Korea MFDS approval status requires separate confirmation, and individual results and duration of effect vary considerably.
3. Suitability and the approach to treatment depend on skin condition, goals, and combination with other procedures, so an individual pre-treatment consultation is always required.
1. What Is InMode? RF-Based Principles
InMode is an RF (Radio Frequency) energy-based medical-device platform developed by an Israeli medical technology company. The system connects different applicators to a single main unit depending on the treatment objective. Leading applicators include Forma (non-invasive bipolar RF), FX (fractional RF), and Morpheus8 (fractional RF microneedling).
The mechanism of RF treatment works as follows. When high-frequency current is delivered into skin tissue, vibration of ions and molecules within the tissue is converted into heat (Joule heating), warming the dermal layer. This thermal stimulus induces collagen fiber denaturation, which is then followed by a wound-healing response that drives new collagen synthesis. The net result — acting in the direction of skin elasticity restoration and remodeling — is the mechanism described in the academic literature.
💡 Fact-check ✓
Source: Bonjorno et al., J Cosmet Dermatol 2020 (PMID 31691477) · FDA accessdata.fda.gov
- RF is described in the literature as acting by "heating the dermis while preserving the epidermis"; immediate collagen denaturation is followed by new collagen formation (PMID 31691477, J Cosmet Dermatol 2020).
- InMode Morpheus8 (Fractora applicator) series: FDA 510(k) clearance K192695 (2019, electrosurgery/hemostasis for dermatologic procedures). This is a 510(k) clearance (substantial-equivalence review) — not PMA (pre-market approval). The article uses the term "clearance" throughout.
- Korea MFDS approval status: for official registration information, please refer to emedi.mfds.go.kr. No definitive statements on license details are made in this article.
- Efficacy and duration of results vary between individuals.
One feature of InMode is that it operates both non-invasive and minimally invasive approaches depending on the applicator. The Forma series uses direct contact with the skin surface (non-invasive), while Morpheus8 delivers RF energy deep into the skin via micro-needles. This difference influences indications and downtime.
2. InMode at a Glance
| Item | Details |
|---|---|
| Device Series | InMode RF platform (InMode Ltd., Israel) |
| Energy Principle | RF (radio frequency) → tissue heating → collagen denaturation and regeneration |
| Key Applicators | Forma/FX (non-invasive bipolar RF), Morpheus8 (fractional RF microneedling), and others |
| Approach | Non-invasive (Forma series) / Minimally invasive (Morpheus8 — micro-needles) |
| US FDA Regulatory Status | Morpheus8: 510(k) clearance (K192695, 2019, etc.). Clearance is substantial-equivalence review — not pre-market approval. Cleared indications per original language: electrosurgery/hemostasis for dermatologic procedures, and others. |
| Korea MFDS Approval | For official information, please refer to emedi.mfds.go.kr. |
| Downtime | Varies considerably by applicator. Non-invasive approaches tend to be shorter; microneedling approaches may involve erythema, swelling, and individual variation. |
| Recommended Sessions and Intervals | Determined during consultation based on individual skin condition and goals |
| Consultation and Treatment | Directly conducted by Dr. Kim Gun-woo, Medical Director |
| Patients Requiring Careful Review | Pacemaker or metal implant wearers, pregnancy/breastfeeding, active skin infection, anticoagulant use, etc. — assessed during pre-treatment consultation |
※ The above is general information. Whether InMode is appropriate for you and the specific approach to your treatment are determined only through a pre-treatment consultation. Individual experience and suitability vary based on skin condition and health status.
3. Differences by Applicator — Forma, FX, and Morpheus8
The applicator name following the InMode device name makes a significant difference to the treatment experience and outcome. The information below is general guidance; the appropriate applicator for you is selected during consultation based on your skin condition and goals.
| Category | Forma / FX Series | Morpheus8 |
|---|---|---|
| Approach | Non-invasive — surface-contact bipolar RF | Minimally invasive — RF delivered deep into dermis and subdermal layers via micro-needles (microneedling) |
| Primary Direction of Action | Superficial dermal heating and collagen remodeling in the direction of elasticity | Fractional RF reaching from dermis to deeper subdermal tissue, in the direction of elasticity and tissue remodeling |
| Downtime | Relatively short (erythema, swelling — individual variation) | May be longer due to needle use (redness, crusting — individual variation) |
| US FDA Regulatory Status | Holds 510(k) clearance (indications: relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation). Separate confirmation required for skin elasticity/lifting indications. | Holds 510(k) clearance (K192695 and others). Includes soft tissue contraction. |
| Pain and Anesthesia | Topical anesthetic cream or none (depending on energy level) | Topical anesthetic cream recommended |
💡 Fact-check ✓
Source: FDA accessdata.fda.gov 510(k) database · Dayan et al., Plast Reconstr Surg Glob Open 2022 (PMC9038493, PMID 35492231)
- Morpheus8 applicator series: FDA 510(k) K192695 (2019, electrosurgery/hemostasis for dermatologic procedures); multiple additional clearances exist. These are 510(k) clearances (substantial-equivalence review), not PMA (pre-market approval).
- InMode EVOKE (hands-free bipolar RF) clinical study (PMC9038493, 2022): 6-month follow-up; mean volume reduction of −3.2/−4.1 cm³ in cheek/submental area; 80.8% self-reported appearance improvement at 3 months. This was a small, single-arm study — results cannot be generalized across all InMode applicators.
- Forma series FDA 510(k) cleared indications per original language: "relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation." Skin elasticity/lifting as a cleared indication is not stated as fact in this article.
- Efficacy and duration of results vary between individuals.
4. What Concerns Lead Patients to Consider InMode?
InMode is not a treatment recommended for everyone. During consultations, we typically discuss the possibility of InMode with patients who mention concerns like the following.
Concerns That May Lead to a Discussion
- Those noticing reduced skin elasticity or sagging with age
- Those considering a lifting-direction approach without surgery
- Those wanting to address pore appearance, skin texture, or fine lines
- Those who want to combine treatments into a comprehensive anti-aging plan
Having these concerns does not automatically mean InMode is the right answer. It means InMode is one option among several to review during consultation. Whether it is appropriate and which applicator to use are determined during an individual pre-treatment consultation.
Situations Where We Advise Caution
- Pacemaker or metal implant near the treatment area
- Pregnancy, breastfeeding, or planning to become pregnant
- Active skin infection, inflammation, or wound in the treatment area
- Current use of anticoagulants or antiplatelet agents
- History of keloid or hypertrophic scarring
- Severe skin laxity that may require a surgical approach
If any of these apply to you, please let us know before the consultation. We will confirm whether treatment is appropriate and, if necessary, discuss alternative management options with you.
5. How an InMode Treatment Proceeds
Below is a general outline of how InMode is conducted at Cellinique. Details may vary depending on the applicator and treatment area.
- Pre-treatment consultation and skin assessment — Dr. Kim Gun-woo, Medical Director, personally reviews your skin condition, degree of laxity, prior treatment history, medications, and any contraindications. This step determines whether InMode is appropriate and which applicator to use.
- Treatment planning — Energy output, applicator selection, treatment area, and combination or sequencing with other procedures are reviewed together.
- Anesthetic preparation — Topical anesthetic cream is applied depending on the applicator and energy level. Morpheus8 requires time for the anesthetic to take effect.
- Treatment application — RF energy is delivered according to the plan. Non-invasive approaches use the handpiece in contact with and gliding across the skin surface; Morpheus8 uses micro-needles to deliver energy to the dermal layer.
- Post-treatment care guidance — Immediate aftercare instructions, recovery process, and the interval to the next session (if needed) are explained individually.
💡 A Patient's Experience — "I used to think all RF lifting treatments were the same. After being told that the applicators differ in how they work and what to expect in terms of downtime, I was able to make a plan that actually suited me." That said, how you feel during treatment and your recovery will vary — if you notice any changes after a session, please feel free to contact Cellinique at any time.
6. InMode Efficacy and Duration — What Is Confirmed to Date
The changes expected from InMode RF treatment fall into two categories: an immediate response and collagen remodeling that progresses over time. Immediate collagen fiber denaturation from RF energy may produce some early sense of change in elasticity; gradual new collagen synthesis is then described in the literature as occurring over the following weeks to months.
That said, the following points should be clearly communicated.
- The degree of efficacy and duration of results vary considerably between individuals. They depend on the age of the skin, degree of laxity, lifestyle, number of sessions, and energy settings — identical results cannot be guaranteed.
- Most clinical studies in the literature are small, single-arm studies limited to a specific applicator, and results are difficult to generalize to all InMode applicators.
- For duration of effect, some references mention 6–12 months post-treatment, but this varies by individual and is not guaranteed. Ongoing maintenance sessions may be helpful for some patients.
💡 Fact-check ✓
Source: Bonjorno et al., J Cosmet Dermatol 2020 (PMID 31691477) · Dayan et al., Plast Reconstr Surg Glob Open 2022 (PMC9038493, PMID 35492231) · Bai et al., J Cosmet Dermatol 2024 (PMC11743280, PMID 39327749)
- RF mechanism: dermal heating → collagen denaturation → new collagen formation (PMID 31691477). Research suggests thermal stimulation may induce collagen proliferation without thermal damage (PMC11743280, 2024).
- InMode EVOKE (bipolar RF) clinical study (PMC9038493): 6-month follow-up; 80.8% self-reported appearance improvement at 3 months. However, this was a small, single-arm study using EVOKE — not the same applicator as Forma/FX; figures cannot be applied to the full InMode range.
- Definitive statements about efficacy and duration figures are not made in this article due to individual variation and limitations in the evidence base.
- Efficacy and duration of results vary between individuals.
7. InMode Side Effects and Precautions
InMode is a procedure using a legitimate medical device. It would be inaccurate to say there are no side effects at all; what occurs differs by applicator, energy output, and skin type.
Commonly Discussed Reactions
- Temporary erythema (redness) and swelling at the treatment area
- Morpheus8 series: temporary crusting, petechiae, and tenderness from microneedling (generally resolves within a few days)
- Sensation of warmth or skin tightness
- Rare cases of post-inflammatory hyperpigmentation (particularly in deeper skin tones)
Less Common But Important Reactions
- Burns or blistering (with excessive energy output or treatment near metal implants)
- Persistent hyperpigmentation or hypopigmentation
- Infection (if post-treatment care after microneedling is inadequate)
- Scar formation (rare; more likely in those predisposed to keloid formation)
Information to Share Before Treatment
- Pacemaker or metal implant in the treatment area (may be a contraindication for RF)
- Pregnancy or breastfeeding status (including if you are planning to become pregnant)
- Current medications (especially anticoagulants, antiplatelet agents, immunosuppressants)
- Active skin infection, inflammation, or wound in the treatment area
- History of keloid or hypertrophic scarring
- Recent laser or other procedure history (interval adjustments may be required)
The safety and stability of outcomes depend greatly on the practitioner's experience, energy settings, and post-treatment management. At Cellinique, Dr. Kim Gun-woo, Medical Director, personally handles consultations, treatments, and post-treatment check-ins to ensure consistent care throughout.
8. InMode vs. Other Lifting Treatments
Beyond InMode, there are several options for lifting and elasticity concerns. Rather than a simple comparison of "which is better," the more important question is whether the underlying principle and conditions of each treatment are right for your skin — something assessed together during consultation.
| Category | InMode RF | HIFU Series (Ulthera, Derma Focus, etc.) | Thread Lifting |
|---|---|---|---|
| Energy / Approach | RF (radio frequency) — dermal heating | HIFU (high-intensity focused ultrasound) — focal heating of deep skin layers (SMAS, etc.) | Thread insertion (PDO, PCL, etc.) — mechanical traction and collagen stimulation |
| Depth of Action | From superficial to deep dermis, depending on applicator | From subcutaneous fat down to the SMAS layer | The layer in which threads are placed (dermis to subcutaneous) |
| Downtime | Non-invasive: relatively short / Morpheus8: comparatively longer | Non-invasive: relatively short (transient erythema and swelling) | Longer due to the nature of an implantation procedure |
| Recommended Sessions and Intervals | Determined during consultation based on individual skin condition and goals | ||
It is uncommon for a single treatment to address every concern. Combining treatments with different depths of action and mechanisms — carefully sequenced and spaced — is also something we can plan together during consultation.
9. How Cellinique Operates InMode
Cellinique (Gangnam, Dosan-daero) has InMode available and incorporates it as one option to consider when consulting on lifting and elasticity management, based on each patient's individual skin profile. RF energy output and applicator selection are critical design decisions that significantly influence outcomes, and they are finalized during an unhurried consultation.
Dr. Kim Gun-woo, Medical Director, personally handles every step from the initial consultation through treatment and post-treatment check-in. When combining InMode with other procedures, he gives careful attention to sequencing and interval design. The belief is that a combined plan tailored to the individual's skin condition and long-term care goals matters more than the outcome of any single treatment session.
The Dosan-daero location makes repeat visits and progress check-ins straightforward — an advantage for RF-based procedures where collagen remodeling changes develop and are confirmed together over time.
Frequently Asked Questions (FAQ)
Q1. How long do InMode results last?
Duration depends on the applicator, energy output, individual skin condition, and lifestyle — it is not possible to give a uniform answer. Some references mention 6 months to a year, but individual variation is significant and results are not guaranteed. Periodic maintenance sessions can be helpful for some patients; the right interval for you will be discussed during consultation.
Q2. Has InMode received US FDA regulatory clearance?
Some InMode devices hold US FDA 510(k) clearance. 510(k) clearance is not pre-market approval (PMA) — it is a review that confirms substantial equivalence to a previously cleared device. The Morpheus8 applicator holds K192695 (2019) among multiple clearances. Korea MFDS approval status will be explained during consultation.
Q3. Is InMode treatment painful?
Sensation varies by applicator and energy output. The non-invasive Forma series tends to feel like a warm heat sensation and is generally comfortable; Morpheus8 (microneedling) can be more uncomfortable during treatment and topical anesthetic cream is used. Individual pain thresholds differ, so experiences vary.
Q4. What is the downtime like?
It depends on the applicator. Non-invasive approaches typically show some redness on the day of treatment that tends to fade relatively quickly; Morpheus8, due to the microneedles, may involve a few days of redness, crusting, and swelling. We recommend allowing some buffer time before important events. Your specific recovery timeline will be covered during consultation.
Q5. Is one session enough, or do I need multiple sessions?
Recommended sessions vary by skin condition, goals, and applicator. Some patients have a single session; others have a series of sessions at set intervals. There is no single correct number — an individual plan is provided during the initial consultation.
Q6. Can I combine InMode with other treatments?
Whether combination is appropriate depends on the types of treatments currently being received, timing, and recovery status. When combining with lasers, botulinum toxin, fillers, or skin boosters, sequence and interval design are important. Please share your current treatments and medications accurately at the pre-treatment consultation so we can coordinate accordingly.
Q7. What should I do if I experience a side effect?
Temporary erythema, swelling, and crusting at the treatment area typically resolve within a few days. However, if you experience severe swelling, fever, persistent heat, ongoing pigment changes, or a burning sensation, please contact Cellinique immediately at 02-6203-3434. Post-treatment care is managed directly by the attending physician.
Q8. Can I come in for a consultation only?
Of course. InMode is a treatment where the applicator, energy settings, and combination with other procedures differ for each person, and we very much recommend fully understanding it before making a decision. Whether or not you proceed with treatment, consultations are welcome — please contact us at 02-6203-3434 or via KakaoTalk. Consultation and treatment costs vary based on individual condition and treatment plan, and will be explained during your consultation.
In Closing
InMode is not a treatment to receive simply because it is well-known. It is a treatment to consider — after a pre-treatment consultation and skin assessment — for those who need care directed at inducing collagen remodeling via RF energy. Because applicator selection and energy design have a major influence on outcomes, the practitioner's understanding and individual planning matter far more than device brand recognition.
At Cellinique (Gangnam, Dosan-daero), Dr. Kim Gun-woo, Medical Director, personally handles everything from the initial consultation through treatment and post-treatment check-in. If you are interested in InMode, we suggest starting with an open conversation about your skin condition and goals — the consultation is the right place to begin. For comparisons with other lifting treatments, visit the Cellinique Lifting Treatment Information page; for information on skin boosters, see the Skin Booster Comparison Guide.
Individual results, duration, and suitability vary based on personal skin condition, age, and lifestyle patterns, and identical outcomes cannot be guaranteed for everyone.
All procedures carry the possibility of temporary side effects such as erythema and swelling. Contraindications may apply — please confirm during your pre-treatment consultation.
✅ Fact-check Report
The key medical information in this article was verified against the following sources.
- FDA accessdata.fda.gov 510(k) database — Confirmed existence of 510(k) clearance K192695 (2019) for Morpheus8 (Fractora) applicator. Documented in-text as 510(k) clearance, not PMA pre-market approval (no approval claim made). Cleared indications per original language (electrosurgery/hemostasis for dermatologic procedures). Forma series cleared indications per original language (minor muscle aches/pain relief, muscle spasm relief, temporary improvement of local blood circulation) confirmed. Skin elasticity/lifting as a cleared indication is not stated as fact in this article.
- Korea MFDS (MFDS) approval status — MFDS approval is referenced in some sources; for official confirmation please refer to emedi.mfds.go.kr. No definitive statements on license details are made in this article.
- Bonjorno et al., J Cosmet Dermatol 2020 (PMID 31691477) — RF mechanism confirmed (dermal heating → collagen denaturation → new collagen formation).
- Dayan et al., Plast Reconstr Surg Glob Open 2022 (PMC9038493, PMID 35492231) — InMode EVOKE (hands-free bipolar RF) clinical study. 6-month follow-up; 80.8% self-reported appearance improvement at 3 months. Documented as a small, single-arm study.
- Bai et al., J Cosmet Dermatol 2024 (PMC11743280, PMID 39327749) — Confirmed that RF thermal stimulation may induce collagen proliferation without thermal damage. Note: this study used a specific bipolar RF device (Reaction, Sinclair Co.) — not identical to InMode devices.
- Verified items: RF mechanism (collagen remodeling), existence of US FDA clearance (510(k), not approved), side effect types, contraindications. Definitive statements on efficacy figures, duration, or Korea MFDS approval figures are not used in this article.
Medical Disclaimer
This content is provided for general health information purposes only. Individual diagnostic assessment, procedure suitability, and expected outcomes must be determined through a consultation with a qualified medical professional. All medical procedures carry individual variation and the possibility of side effects.
Cellinique — Consultation and Appointments
2F & B1, Yeonseung Building, 228 Dosan-daero, Gangnam-gu, Seoul
Tel: 02-6203-3434
Hours: Mon–Fri 10:00–19:00 / Last Saturday of each month 10:00–16:30
